Advertisement
Canada markets open in 5 hours 35 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7312
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    83.38
    +0.02 (+0.02%)
     
  • Bitcoin CAD

    91,168.92
    +560.55 (+0.62%)
     
  • CMC Crypto 200

    1,418.29
    -5.81 (-0.41%)
     
  • GOLD FUTURES

    2,334.30
    -7.80 (-0.33%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,715.00
    +108.25 (+0.61%)
     
  • VOLATILITY

    15.74
    +0.05 (+0.32%)
     
  • FTSE

    8,073.25
    +28.44 (+0.35%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

What's Behind Gilead Sciences Drop In Hepatitis C Sales?

Gilead Sciences' Harvoni sales are dipping, as cost cutting to expand the addressable patient population kicks in.

This podcast was recorded on May 4, 2016.